Clinical Trial Update: Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients

View source ↗

Summary

This completed clinical trial update from the National Cancer Institute investigates molecular pathways in medullary thyroid carcinoma and correlates molecular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma
• Multiple Endocrine Neoplasia Type 2

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2 | Status: COMPLETED